Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limitedverified

CUV.AX

Price:

$11.54

Market Cap:

$577.70M

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a c...[Read more]

Industry

Biotechnology

IPO Date

2001-02-11

Stock Exchange

ASX

Ticker

CUV.AX

The ROE as of January 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CUV.AX) is 18.67%

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 18.67%. This represents a change of 95.83% compared to the average of 9.54% of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CUV.AX) Historical ROE (quarterly & annually)

How has CUV.AX ROE performed in the past?

The mean historical ROE of Clinuvel Pharmaceuticals Limited over the last ten years is 8.43%. The current 18.67% ROE has changed 121.61% with respect to the historical average. Over the past ten years (40 quarters), CUV.AX's ROE was at its highest in in the June 2018 quarter at 29.89%. The ROE was at its lowest in in the December 2014 quarter at -57.47%.

Quarterly (TTM)
Annual

Average

8.43%

Median

20.84%

Minimum

-92.66%

Maximum

33.55%

Clinuvel Pharmaceuticals Limited (CUV.AX) ROE by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 158.70%

Maximum Annual ROE = 33.55%

Minimum Annual Increase = -261.28%

Minimum Annual ROE = -92.66%

Quarterly (TTM)
Annual
YearROEChange
202417.55%-5.57%
202318.59%11.80%
202216.63%-33.60%
202125.04%8.42%
202023.10%-27.16%
201931.71%-5.47%
201833.55%18.61%
201728.29%-261.28%
2016-17.54%-81.07%
2015-92.66%158.70%

Clinuvel Pharmaceuticals Limited (CUV.AX) Average ROE

How has CUV.AX ROE performed in the past?

The current ROE of Clinuvel Pharmaceuticals Limited (CUV.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

17.59%

5-year avg

20.18%

10-year avg

8.43%

Clinuvel Pharmaceuticals Limited (CUV.AX) ROE vs. Peers

How is CUV.AX’s ROE compared to its peers?

Clinuvel Pharmaceuticals Limited’s ROE is less than Pro Medicus Limited (47.73%), less than Nanosonics Limited (7.25%), less than PolyNovo Limited (7.45%), less than Fisher & Paykel Healthcare Corporation Limited (7.55%), greater than AVITA Medical, Inc. (-39.79%),

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CUV.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CUV.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Clinuvel Pharmaceuticals Limited's ROE?

How is the ROE calculated for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the highest ROE for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the 3-year average ROE for Clinuvel Pharmaceuticals Limited (CUV.AX)?

What is the 5-year average ROE for Clinuvel Pharmaceuticals Limited (CUV.AX)?

How does the current ROE for Clinuvel Pharmaceuticals Limited (CUV.AX) compare to its historical average?